Biochemical Programs of Slowly and Rapidly Growing Human Colon Carcinoma Xenografts
Overview
Affiliations
Wang Y, Liu S, Tian S, Du R, Lin T, Xiao X Int J Med Sci. 2022; 19(5):842-857.
PMID: 35693733 PMC: 9149634. DOI: 10.7150/ijms.71703.
Sprangers B, Nair V, Launay-Vacher V, Riella L, Jhaveri K Clin Kidney J. 2018; 11(3):315-329.
PMID: 29942495 PMC: 6007332. DOI: 10.1093/ckj/sfx122.
Xanthine oxidoreductase in cancer: more than a differentiation marker.
Battelli M, Polito L, Bortolotti M, Bolognesi A Cancer Med. 2015; 5(3):546-57.
PMID: 26687331 PMC: 4799950. DOI: 10.1002/cam4.601.
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.
Linder N, Haglund C, Lundin M, Nordling S, Ristimaki A, Kokkola A J Clin Pathol. 2006; 59(9):965-71.
PMID: 16935971 PMC: 1860491. DOI: 10.1136/jcp.2005.032524.
Eroglu A, Canbolat O, Demirci S, Kocaoglu H, Eryavuz Y, Akgul H Med Oncol. 2000; 17(4):319-24.
PMID: 11114712 DOI: 10.1007/BF02782198.